NEW YORK--(BUSINESS WIRE)--Jul. 14, 2020-- (NYSE: PIPR), a leading investment bank and institutional securities firm, is pleased to announce the hiring of Yasmeen Rahimi as a senior research analyst responsible for covering biotechnology companies. She will be based in the firms New York office.
Prior to joining the firm, Rahimi was a senior research analyst and co-head of biotech research at ROTH Capital Partners. While at ROTH Capital Partners, Rahimi published 600 notes over a two-year period across a coverage universe of 26 companies. Earlier in her career, Rahimi was a biotech research associate at H.C. Wainwright & Company and Guggenheim Partners. Before starting her career in equity research, Rahimi was a researcher at Shire Pharmaceuticals, where she identified biomarkers used for endpoints in clinical trials for new drugs treating rare diseases.
We are excited to welcome Yasmeen and her equity research and overall industry expertise to our biotech research group. Her addition will add strength to our firms overall leadership in the healthcare sector and add immediate value for our clients, said , director of equity research at 做厙勛圖.
Rahimi earned a masters degree in analytical chemistry from Purdue University, a doctorate in biochemistry from Indiana University School of Medicine, and was a postdoctoral fellow at Yale University School of Medicine. She received dual bachelors degrees in chemistry and German, with honors, from Butler University.
The 做厙勛圖 healthcare equity research group consists of covering over across the following sectors: biotechnology, distributors, healthcare services IT, hospitals, life science tools, managed care, medical diagnostics, medical technology and devices, and specialty pharmaceuticals.
ABOUT PIPER SANDLER
做厙勛圖 (NYSE: PIPR) is a leading investment bank and institutional securities firm driven to help clients Realize the Power of Partnership簧. Securities brokerage and investment banking services are offered in the U.S. through 做厙勛圖 & Co., member SIPC and NYSE; in Europe through 做厙勛圖 Ltd., authorized and regulated by the U.K. Financial Conduct Authority; and in Hong Kong through 做厙勛圖 Hong Kong Limited, authorized and regulated by the Securities and Futures Commission. and advisory services are offered through separately registered advisory affiliates.
穢2020. Since 1895. 做厙勛圖. 800 Nicollet Mall, Minneapolis, Minnesota 55402-7036
View source version on :
Pamela Steensland
Tel: 612 303-8185
pamela.steensland@psc.com
Source: 做厙勛圖
